TENX
Tenax Therapeutics Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 0 | 0 | 0 | 49,286 | 158,926 | 1.2M | 363,781 | 103,167 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | 0 | 0 | -104,069 | 49,572 | 49,266 | 103,167 |
| Operating Expenses | ||||||||
| R&D Expenses | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Total Op. Expenses | — | — | — | — | — | — | — | — |
| Operating Income | -56.4M | -19.5M | -52.7M | -14.8M | -16.6M | -5.2M | -8.2M | 10.6M |
| EBITDA | — | — | — | — | — | — | — | — |
| Below the Line | ||||||||
| Interest Expense | — | — | — | — | — | — | — | — |
| Pre-Tax Income | — | — | — | — | — | — | — | — |
| Income Tax | — | — | — | — | — | — | — | — |
| Net Income | -52.6M | -17.6M | -43.9M | -14.1M | -19.5M | -9.4M | -15.7M | 10.4M |
| Per Share | ||||||||
| EPS (basic) | — | — | — | — | — | — | — | — |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Shares | ||||||||
| Basic Shares | — | — | — | — | — | — | — | — |
| Diluted Shares | 39M | 15M | 1M | 28M | 9M | 2M | 1M | 23M |